Fixed-dose combination therapy for the prevention of cardiovascular disease

Mapping Intimacies ◽

10.1002/14651858.cd009868.pub2 ◽

2014 ◽

Cited By ~ 21

Author(s):

Angharad N de Cates ◽

Matthew RB Farr ◽

Nicola Wright ◽

Morag C Jarvis ◽

Karen Rees ◽

...

Keyword(s):

Cardiovascular Disease ◽

Combination Therapy ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Dose Combination ◽

Prevention Of Cardiovascular Disease

Download Full-text

Fixed-dose combination therapy for the prevention of cardiovascular disease

10.1002/14651858.cd009868 ◽

2012 ◽

Author(s):

Angharad N de Cates ◽

Matthew RB Farr ◽

Karen Rees ◽

Juan P Casas ◽

Mark Huffman

Keyword(s):

Cardiovascular Disease ◽

Combination Therapy ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Dose Combination ◽

Prevention Of Cardiovascular Disease

Download Full-text

Fixed-Dose Combination Therapy (Polypill) for the Prevention of Cardiovascular Disease

JAMA ◽

10.1001/jama.2014.13616 ◽

2014 ◽

Vol 312 (19) ◽

pp. 2030 ◽

Cited By ~ 7

Author(s):

Mark D. Huffman ◽

Angharad N. de Cates ◽

Shah Ebrahim

Keyword(s):

Cardiovascular Disease ◽

Combination Therapy ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Dose Combination ◽

Prevention Of Cardiovascular Disease

Download Full-text

Fixed-dose combination therapy to reduce the growing burden of cardiovascular disease in low- and middle-income countries: feasibility and challenges

Journal of Clinical Hypertension ◽

10.1111/jch.13162 ◽

2018 ◽

Vol 20 (1) ◽

pp. 168-173 ◽

Cited By ~ 3

Author(s):

Jobert Richie Nansseu ◽

Aurel T. Tankeu ◽

Joseph Kamtchum-Tatuene ◽

Jean Jacques Noubiap

Keyword(s):

Cardiovascular Disease ◽

Combination Therapy ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Middle Income ◽

Middle Income Countries ◽

Dose Combination ◽

Low And Middle Income

Download Full-text

What are the benefits and harms of fixed-dose combination therapy for primary or secondary prevention of atherosclerotic cardiovascular disease?

Cochrane Clinical Answers ◽

10.1002/cca.1897 ◽

2018 ◽

Keyword(s):

Cardiovascular Disease ◽

Combination Therapy ◽

Secondary Prevention ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Atherosclerotic Cardiovascular Disease ◽

Dose Combination

Download Full-text

Cost-effectiveness of a fixed-dose combination pill for secondary prevention of cardiovascular disease in China, India, Mexico, Nigeria, and South Africa: a modelling study

The Lancet Global Health ◽

10.1016/s2214-109x(19)30339-0 ◽

2019 ◽

Vol 7 (10) ◽

pp. e1346-e1358 ◽

Cited By ~ 5

Author(s):

John K Lin ◽

Andrew E Moran ◽

Kirsten Bibbins-Domingo ◽

Bode Falase ◽

Andrea Pedroza Tobias ◽

...

Keyword(s):

South Africa ◽

Cardiovascular Disease ◽

Cost Effectiveness ◽

Secondary Prevention ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Dose Combination ◽

Combination Pill ◽

Prevention Of Cardiovascular Disease ◽

Modelling Study

Download Full-text

PCV53 COST-EFFECTIVENESS OF THE CNIC POLYPILL - FIXED DOSE COMBINATION OF ACETYLSALICYLIC ACID, RAMIPRIL AND ATORVASTATIN - FOR THE SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE IN GREECE

Value in Health ◽

10.1016/j.jval.2019.09.778 ◽

2019 ◽

Vol 22 ◽

pp. S550

Author(s):

G. Ntaios ◽

K. Vemmos ◽

P. Papapetrou ◽

S. Zafeiri ◽

G. Rubio

Keyword(s):

Cardiovascular Disease ◽

Cost Effectiveness ◽

Secondary Prevention ◽

Acetylsalicylic Acid ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Dose Combination ◽

Prevention Of Cardiovascular Disease

Download Full-text

Polypill (fixed-dose combination) in the prevention of cardiovascular disease: rationale and clinical data

Clinical Investigation ◽

10.4155/cli.12.127 ◽

2012 ◽

Vol 2 (12) ◽

pp. 1213-1229 ◽

Cited By ~ 2

Author(s):

Kavita Singh ◽

Abdul Salam ◽

Raji Devarajan ◽

Anushka Patel ◽

Dorairaj Prabhakaran

Keyword(s):

Cardiovascular Disease ◽

Clinical Data ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Dose Combination ◽

Prevention Of Cardiovascular Disease

Download Full-text

Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis

The Lancet ◽

10.1016/s0140-6736(21)01827-4 ◽

2021 ◽

Cited By ~ 1

Author(s):

Philip Joseph ◽

Gholamreza Roshandel ◽

Peggy Gao ◽

Prem Pais ◽

Eva Lonn ◽

...

Keyword(s):

Cardiovascular Disease ◽

Primary Prevention ◽

Meta Analysis ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Individual Participant Data ◽

Combination Therapies ◽

Individual Participant ◽

Dose Combination ◽

Prevention Of Cardiovascular Disease

Download Full-text

Efficacy of Olmesartan Medoxomil and Hydrochlorothiazide Fixed-Dose Combination Therapy in Patients Aged 65 Years and Older with Stage 1 and 2 Hypertension or Isolated Systolic Hypertension

American Journal of Cardiovascular Drugs ◽

10.2165/11635000-000000000-00000 ◽

2012 ◽

Vol 12 (5) ◽

pp. 325-333 ◽

Cited By ~ 1

Author(s):

F. Wilford Germino ◽

Joel M. Neutel ◽

Robert Dubiel ◽

Jen-Fue Maa ◽

Kathleen J. Chavanu

Keyword(s):

Combination Therapy ◽

Systolic Hypertension ◽

Olmesartan Medoxomil ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Isolated Systolic Hypertension ◽

Dose Combination ◽

Stage 1

Download Full-text

Single-Pill Triple Fixed Dose Combination Therapy with Single Component Drug Monitoring in Treatment-Resistant Hypertension: A Pilot Study

Current Vascular Pharmacology ◽

10.2174/1570161115666170821155555 ◽

2018 ◽

Vol 16 (2) ◽

pp. 197-203 ◽

Cited By ~ 1

Author(s):

Reinhold Kreutz ◽

Jurgen Scholze ◽

Antonios Douros

Keyword(s):

Pilot Study ◽

Combination Therapy ◽

Drug Monitoring ◽

Resistant Hypertension ◽

Single Component ◽

Fixed Dose Combination ◽

Fixed Dose ◽

Treatment Resistant ◽

Single Pill ◽

Dose Combination

Download Full-text